Changes in Hong Kong stocks | Minimally Invasive Brain Science (02172) is now up more than 5%, and the brain-computer interface industry has ushered in a capital boom. Companies are involved in domestic enterprises with head nerves

The Zhitong Finance App learned that Minimally Invasive Brain Science (02172) is now up more than 5%. As of press release, it has risen 5.51% to HK$13.02, with a turnover of HK$796.721 million.

According to the news, Neuralink, a brain-computer interface startup owned by Musk, has previously completed Series E financing of 650 million US dollars, showing that the popularity of capital in the brain-computer industry continues to rise. Furthermore, at 2 a.m. on June 6, Chinese scientists successfully developed the world's first visual prosthesis with ultra-wide spectral responsiveness using brain-computer interface and other technologies in the latest research results launched in the “Science” (Science) magazine.

It is worth noting that the National Health Insurance Administration recently set up an independent charging program for new brain-computer interface technology to remove barriers to commercialization. Under the “technology+policy” two-wheel drive, the commercialization process of domestic enterprises is expected to accelerate. According to public information, minimally invasive brain science products comprehensively cover hemorrhagic stroke, atherosclerotic stenosis, and acute ischemic stroke. According to Frost & Sullivan statistics, based on 2023 sales revenue, minimally invasive brain science has risen to fourth place in the market share of neurointerventional medical devices in China, and has maintained the number one position in domestic market share in recent years.